RCKT - Rocket Pharmaceuticals Short-Term Debt to Capital

Graphic logo of Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals (RCKT) is integrating ESG ethical standards into gene therapy and strictly monitoring biohazardous waste disposal. The share price history with the 0.01 indicator links these principles to the development of viral vectors for treating fatal pediatric pathologies. Robotic systems are accelerating the drug discovery process, automatically analyzing genetic sequences in sterile zones 24/7.

Ratio of Short-Term Indebtedness to Capital: Rocket Pharmaceuticals Inc (RCKT) for 07/04/2022 - 10/30/2026

Metric breakdowns and analytics for rocketpharma.com (RCKT)

- stock value and consensus price forecast:
Price Chart Rocket Pharmaceuticals Inc|RCKT - Broker Consensus Forecast
- market capitalization statistics:
Market Capitalization Rocket Pharma|RCKT - Enterprise Value
- book capitalization information:
Net Assets per Single Share Rocket Pharmaceuticals|RCKT - Accounting Value of Company|Market Value to Book Value Ratio rocketpharma.com|RCKT - Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Rocket Pharmaceuticals|RCKT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Rocket Pharmaceuticals, Inc.|RCKT - Company Aggregate Debts|Debts to Book Capitalization Rocket Pharma|RCKT - Long-Term Debt|Company Current Liabilities Rocket Pharmaceuticals|Quick Liquidity Indicator rocketpharma.com
- company profitability and valuation multiples indicators:
RCKT - Final Profit
Comprehensive company analysis:Rocket Pharmaceuticals Inc
Brand item of Rocket Pharmaceuticals, Inc.

Diversified biocomponent supply chains ensure operational cycle stability for Rocket Pharmaceuticals (RCKT). An analysis of the current loan-to-equity ratio allows for an assessment of the company's reliance on short-term debt financing. This metric compares current liabilities with shareholder equity, identifying the risk of insolvency in the event of a sharp increase in debt. Low indicator values confirm financial stability and minimize the probability of bankruptcy.

Competitors of Rocket Pharmaceuticals (RCKT)

Short-Term Debt to Equity Tempus AI (TEM)|Qiagen Corp - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IONS (Ionis Pharmaceuticals)|Short-Term Debt to Capital repligen.com RGEN|RNA - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital CRSP (CRISPR Therapeutics Inc)|Sema4 (WGS) - Short-Term Debt to Equity|Current Liabilities to Capital Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio sarepta.com (SRPT)|Short-Term Debt to Equity Twist Bioscience, Inc. (TWST)|Short-Term Debt to Capital 10x Genomics Inc (TXG)|Short-Term Debt to Capital NTLA (Intellia)|Stoke Corp (STOK) - Current Liabilities to Capital|BLFS: Short-Term Debt to Equity Ratio|wavelifesciences.com - Short-Term Loans to Capital Ratio|MAZE (Maze Therapeutics) - Short-Term Debt to Equity Ratio|Sionna Therapeutics, Inc. - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Prime Medicine Corp|Taysha Corp - Current Liabilities to Equity|Short-Term Debt to Capital QURE|MGTX (meiragtx.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital RGNX (REGENXBIO)|Short-Term Debt to Capital Solid Biosciences Inc SLDB|OCGN - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PACB (PacBio Corp)|Benitec Biopharma Inc. (BNTC) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio designtx.com|FDMT (4D Molecular Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Lexeo|Short-Term Debt to Capital KRRO|Short-Term Debt to Equity Ratio Editas Corp EDIT|Short-Term Debt to Capital SLN (Silence Therapeutics)|ProQR (PRQR) - Current Liabilities to Capital|CDXS: Short-Term Debt to Equity Ratio|SGMO - Short-Term Debt to Capital|NAUT (nautilus.bio) - Short-Term Debt to Equity Ratio|MGX: Short-Term Loans to Capital Ratio|DTIL (Precision BioSciences) - Short-Term Debt to Capital|Generation Bio Corp (GBIO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital BOLD|Short-Term Debt to Equity Ratio exicuretx.com XCUR|Short-Term Debt to Capital IMNN (Imunon)|Short-Term Debt to Capital Phio Pharmaceuticals Corp PHIO|MBIO - Short-Term Debt to Equity|RNAZ: Short-Term Debt to Equity|bionanogenomics.com (BNGO) - Short-Term Debt to Equity|APDN - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Bluebird Bio|IPA: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital OMGA|Short-Term Debt to Equity Ratio singulargenomics.com OMIC|Short-Term Debt to Equity Regulus Therapeutics Inc. RGLS|Short-Term Debt to Capital Syros Pharmaceuticals Inc. SYRS|TBIO: Short-Term Debt to Equity Ratio|TRACON Pharmaceuticals, Inc - Short-Term Loans to Capital Ratio|UBX: Short-Term Debt to Capital